Summary
Insulin resistance was assessed after an intravenous infusion of adrenaline (50 ng·kg−1·min−1) or saline (control study) given between 08.00 and 08.30 hours in nine patients with Type 1 (insulin-dependent) diabetes mellitus. The blood glucose level during a somatostatin (100μg/h)-insulin (0.4mU·kg−1·min−1)-glucose (4.5 mg·kg−1·-min−1)-infusion-test performed between 1030 and 14.30 hours served as an indicator of the total body insulin resistance. Blood glucose was maintained around 7 mmol/l between 08.00 and 10.30 hours by a constant infusion of regular insulin (0.57 mU·kg−1· min−1) and a variable infusion of a 20% glucose solution. The infusion of adrenaline raised plasma adrenaline to 2.7±0.3 nmol/l (mean±SEM) at the end of the infusion; thereafter it returned to its basal level within 30 min. The plasma levels of free insulin, glucagon, cortisol and growth hormone were similar in the adrenaline and the control studies from 08.00 to 14.30 hours. In comparison with the control study the infusion of adrenaline decreased the need for intravenous glucose significantly over the initial 2 h. Furthermore, during the somatostatin-insulin-glucose infusion test the blood glucose rose significantly (p<0.05) over the initial 2h; thereafter no significant differences between the two studies were seen. It is concluded that a short term infusion of adrenaline, resembling the adrenergic hormone response to hypoglycaemia, induces a diabetogenic effect which subsides within 6 h after omission of the adrenaline infusion.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Rizza RA, Cryer PE, Gerich JE (1979) Role of glucagon, catecholamines, and growth hormone in human glucose counter-regulation. Effects of somatostatin and combined alpha and beta adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycaemia. J Clin Inves 64: 62–71
Kollind M, Adamson U, Lins PE (1987) Insulin resistance following nocturnal hypoglycemia in insulin-dependent diabetes mellitus. Acta Endocrinol 116: 314–320
Kollind M, Adamson U, Lins PE, Efendic S (1987) Diabetogenic action of GH and cortisol in insulin-dependent diabetes mellitus. Aspects of the mechanisms behind the Somogyi phenomenon. Horm Metab Res 19: 156–159
Thomas AE, Kay DA, Cutlip MB (1976) A nomograph method for assessing body weight. Am J Clin Nutr 29: 302–304
Page MM, Watkins PJ (1978) Cardiorespiratory arrest and diabetic autonomie neuropathy. Lancet: 14–20
Angelone A, Coulter NA (1964) Respiratory sinus arrhytmia: a frequency dependent phenomenon. J Appl Physiol 19: 479–482
Nakagawa S, Nakayama H, Sasaki T, Yoshino K, Yu YY, Shinozaki K, Aoki S, Mashimo K (1973) A simple method for the determination of serum free insulin levels in insulin treated patients. Diabetes 22: 590–600
Cerasi E, Delia Casa L, Luft R, Roovete A (1966) Determination of human growth hormone (HGH) in plasma by a double antibody radioimmunoassay. Acta Endocrinol (Copenh) 53: 101–120
Lantto O, Lindbäck B, Aakvaag A, Damkjaer-Nielsen M, Pomoell UM, Björkhem I (1983) Assay of cortisol with a radioimmunoassay method calibrated by isotopic dilution mass-spectrometri. A nordic collaborative study. Scand J Clin Invest 43: 433–477
Faloona GR, Unger RH (1974) Glucagon. In: Jaffe BM, Behrman HR (eds) Methods of hormone radioimmunoassay. Academic Press, New York London 317–330
Hallman H, Farnebo LO, Hamberger B, Jonsson G (1978) A sensitive method for determination of plasma catecholamines using liquid chromatography with electrochemical detection. Life Sci 23: 1049–1052
Jeppson JO, Franzen B, Nilsson KO (1978) Determination of glycosylated hemoglobin fraction HbA1 c in diabetes mellitus by thin-layer electro-focusing. Science Tools 25: 69–72
Heding JG (1975) Radioimmunological determination of human C-peptide in serum. Diabetologia 11: 541–548
Schlichtkrull J, Munck O, Jersild M (1965) The M-value, an index of blood glucose control in diabetics. Acta Med Scand 177: 95–102
Rizza RA, Cryer PE, Haymond MW, Gerich JE (1980) Adrenergic mechanisms for the effects of epinephrine on glucose production and clearance in man. J Clin Invest 65: 682–689
Popp DA, Shah SD, Cryer PE (1982) Role of epinephrine-mediated beta-adrenergic mechanisms in hypoglycemic glucose counterregulation and posthypoglycemic hyperglycemia in insulin-dependent diabetes mellitus. J Clin Invest 69: 315–326
Attvall S, Fowelin J, von Schenk H, Lager I, Smith U (1987) Insulin resistance in Type 1 (insulin dependent) diabetes following hypoglycaemia-evidence for the importance of beta-adrenergic stimulation. Diabetologia 30: 691–697
Bolli GB, Gottesman IS, Campbell PJ, Haymond MW, Cryer PE, Gerich JE (1984) Glucose counterregulation and waning of insulin in the Somogyi phenomenon (posthypoglycemic hyperglycemia). N Engl J Med 311: 1214–1219
Kleinbaum J, Shamoon H (1984) Effect of propranolol on delayed glucose recovery after insulin-induced hypoglycemia in normal and diabetic subjects. Diabetes Care 7: 155–162
Blackard WG, Heidingsfelder SA (1968) Adrenergic receptor control mechanisms for growth hormone secretion. J clin Invest 47: 1407–1414
Benson JW, Johnson DG, Palmer JP, Werner PL, Ensinck JW (1977) Glucagon and catecholamine secretion during hypoglycemia in normal and diabetic man. J Clin Endocrinol Metab 44: 459–464
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kollind, M., Adamson, U., Lins, P.E. et al. Transient insulin resistance following infusion of adrenaline in Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 31, 603–606 (1988). https://doi.org/10.1007/BF00264767
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00264767